Literature DB >> 21288119

Medication refusal in children with oppositional defiant disorder or conduct disorder and comorbid attention-deficit/hyperactivity disorder: medication history and clinical correlates.

Mark Demidovich1, David J Kolko, Oscar G Bukstein, Jonathan Hart.   

Abstract

UNLABELLED: Abstract Objective: This study examines the characteristics of 96 children with attention-deficit/hyperactivity disorder (ADHD) and their families who refused a recommendation for medication as part of their treatment for disruptive disorders.
METHODS: The ADHD cases were taken from a sample of 139 youth (age 6-11) who were recruited for a clinical trial that compared the administration of a modular psychosocial treatment in an outpatient clinic or community settings. Medication management was an optional treatment module for children with ADHD in both conditions. Children who were (vs. were not) taking medication at intake, and children who accepted (vs. refused) medication recommendations during the study were compared on diagnostic and clinical measures related to child, school, parent, and family domains of functioning.
RESULTS: Parents of 30% of the children refused study medication for ADHD. Parental medication acceptability and intake correlated highly with both medication history and study refusal of medication. Increased parental self-efficacy and emotional support for their youth correlated with medication refusal. No demographics and few child or school factors were associated with medication refusal. Medication use was associated with reductions in some key ADHD symptoms, but did not affect disruptive behaviors as did the psychosocial interventions.
CONCLUSION: Medication refusers remain poorly understood but certain correlates, such as parental self-efficacy, parental emotional support for their youth, and medication acceptability, warrant further evaluation.

Entities:  

Mesh:

Year:  2011        PMID: 21288119      PMCID: PMC3037195          DOI: 10.1089/cap.2010.0001

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  35 in total

1.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  1999-12

2.  The SCL-90 and the MMPI: a step in the validation of a new self-report scale.

Authors:  L R Derogatis; K Rickels; A F Rock
Journal:  Br J Psychiatry       Date:  1976-03       Impact factor: 9.319

3.  Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach.

Authors:  Vincent J Monastra
Journal:  Int J Psychophysiol       Date:  2005-10       Impact factor: 2.997

Review 4.  Satisfaction with treatment for attention-deficit/hyperactivity disorder.

Authors:  Oscar G Bukstein
Journal:  Am J Manag Care       Date:  2004-07       Impact factor: 2.229

5.  Children's perceptions of parental behaviors.

Authors:  A Hazzard; A Christensen; G Margolin
Journal:  J Abnorm Child Psychol       Date:  1983-03

6.  Factors associated with children's adherence to stimulant medication.

Authors:  Philip Firestone
Journal:  Am J Orthopsychiatry       Date:  1982-07

Review 7.  Improving psychostimulant adherence in children with ADHD.

Authors:  Alice Charach; Amy Gajaria
Journal:  Expert Rev Neurother       Date:  2008-10       Impact factor: 4.618

8.  Medication compliance in hyperactive children.

Authors:  R E Kauffman; D Smith-Wright; C A Reese; R Simpson; F Jones
Journal:  Pediatr Pharmacol (New York)       Date:  1981

9.  Methods of evaluating methylphenidate in children with attention deficit hyperactivity disorder: acceptability, satisfaction, and compliance.

Authors:  C Johnston; S Fine
Journal:  J Pediatr Psychol       Date:  1993-12

Review 10.  Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement.

Authors:  James Swanson
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

View more
  6 in total

1.  Bidirectional relations between parenting practices and child externalizing behavior: a cross-lagged panel analysis in the context of a psychosocial treatment and 3-year follow-up.

Authors:  Anne Shaffer; Oliver Lindhiem; David J Kolko; Christopher J Trentacosta
Journal:  J Abnorm Child Psychol       Date:  2013-02

2.  Provider Training to Screen and Initiate Evidence-Based Pediatric Obesity Treatment in Routine Practice Settings: A Randomized Pilot Trial.

Authors:  Rachel P Kolko; Andrea E Kass; Jacqueline F Hayes; Michele D Levine; Jane M Garbutt; Enola K Proctor; Denise E Wilfley
Journal:  J Pediatr Health Care       Date:  2016-02-09       Impact factor: 1.812

3.  Updates on treatment of attention-deficit/hyperactivity disorder: facts, comments, and ethical considerations.

Authors:  Aribert Rothenberger; Lillian Geza Rothenberger
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

4.  Exploring stimulant treatment in ADHD: narratives of young adolescents and their parents.

Authors:  Alice Charach; Emanuela Yeung; Tiziana Volpe; Tara Goodale; Susan Dosreis
Journal:  BMC Psychiatry       Date:  2014-04-12       Impact factor: 3.630

5.  Cluster-randomized, controlled 12-month trial to evaluate the effect of a parental psychoeducation program on medication persistence in children with attention-deficit/hyperactivity disorder.

Authors:  Alonso Montoya; Amaia Hervás; Joaquín Fuentes; Esther Cardo; Pepa Polavieja; Javier Quintero; Rosemary Tannock
Journal:  Neuropsychiatr Dis Treat       Date:  2014-06-13       Impact factor: 2.570

6.  No Medication for My Child! A Naturalistic Study on the Treatment Preferences for and Effects of Cogmed Working Memory Training Versus Psychostimulant Medication in Clinically Referred Youth with ADHD.

Authors:  Peter Muris; Dorien Roodenrijs; Lut Kelgtermans; Sonja Sliwinski; Ulrike Berlage; Hanna Baillieux; Anne Deckers; Marieke Gunther; Bertien Paanakker; Ida Holterman
Journal:  Child Psychiatry Hum Dev       Date:  2018-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.